BenzingaBenzinga Japan
BenzingaBenzinga Japan
BenzingaBenzinga Japan
土曜日, 9 26

Halozyme Therapeutics Inc

HALONASDAQ
Trade with Public
Trade with Public
$113.90
-1.32-1.15%
近くで: Sep 25, 5:00 PM EST
$114.18
0.280.25%
時間外: Sep 25, 4:02 PM EST
概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Halozyme Therapeutics Ownership & Insider Activity

Halozyme Therapeutics (HALO) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 9.9% of shares outstanding. Institutional investors hold 74.3%. Over the past 90 days, insiders made 3 sales worth $2.3M.

Shares Outstanding

113.498M

Shares Float

86.585M

Insider Shares Owned

11.265M

Insider % Owned

9.9%

Institutional Shares Held

84.286M

Institutional % Held

74.3%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

0

Sales (90d)

3

$2.3M total

Net Activity

Net Selling

Net Value (90d)

-$2.3M

Halozyme Therapeutics Insider Transactions (Last 6 Months)

すべてのインサイダー取引を見る →
DateInsiderTitleTypeSharesPriceValue
Sep 16, 2026Matthew PosardDIRECTORSELL18.996K$107.74$2.0M
Sep 9, 2026Helen TorleyPRESIDENT AND CEOSELL-OPTIONS—$62.84$5.3M
More with Benzinga EdgeGet Access

Congressional Trading Activity

全ての政府取引を見る →
DateMemberPartyChamberActionAmount
Mar 9, 2026Gilbert Ray CisnerosDHousePurchase$1,001 - $15,000
Mar 24, 2025Gilbert Ray CisnerosDHouseSale (Partial)$1,001 - $15,000
More with Benzinga EdgeGet Access

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

市場データ提供元 Benzinga API

BenzingaBenzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved